Treatment under development halves asthma attacks in trial

Embargoed until: Publicly released: 2021-05-13 07:00

International

What does this mean?

Jump to: MultimediaAttachmentsExpert Reaction

Asthma treatment with the drug Tezepelumab can help those with asthma control the condition, according to a randomized, double-blind, placebo-controlled study funded by the drug's developers. 592 people diagnosed with asthma were given the treatment monthly over the course of a year, with a further 532 asthma sufferers given a placebo drug. Over the year, the rate of asthma attacks in the Tezepelumab group was 0.93, compared to 2.1 in the placebo group. The researchers also reported better lung function and asthma control in the Tezepelumab group after the year.